---
title: "DEERFIELD PRIVATE DESIGN FUND IV, L.P. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/bba401c5-eaa6-57ec-9730-e5eeb88b37f1
json: https://whiteintel.dev/api/public/dossier/bba401c5-eaa6-57ec-9730-e5eeb88b37f1
identifier: sec:0001680307
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# DEERFIELD PRIVATE DESIGN FUND IV, L.P.

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001680307`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/bba401c5-eaa6-57ec-9730-e5eeb88b37f1  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/bba401c5-eaa6-57ec-9730-e5eeb88b37f1  

## Cross-source identity

The same real-world entity, resolved across sources:

- **DEERFIELD PRIVATE DESIGN FUND IV, L.P.** — GLEIF · `lei:549300QJOA5QI17WBG46` — https://whiteintel.dev/entity/f8aaec75-241c-5a6a-88de-fb00867ba5c9

## Ownership & control

### Holdings / subsidiaries

- **Larimar Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/72e3523f-efab-5ee4-b03e-4139df749767
- **Larimar Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/72e3523f-efab-5ee4-b03e-4139df749767
- **Larimar Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/72e3523f-efab-5ee4-b03e-4139df749767
- **Nuvalent, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/c311f0a0-a099-557a-ba70-bfce08965197
- **Nuvalent, Inc.** (director) — https://whiteintel.dev/entity/c311f0a0-a099-557a-ba70-bfce08965197
- **Nuvalent, Inc.** (other) — https://whiteintel.dev/entity/c311f0a0-a099-557a-ba70-bfce08965197
- **ARS Pharmaceuticals, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a9c00c55-4330-55f3-a417-febad978a7c8
- **AdaptHealth Corp.** (tenpercentowner) — https://whiteintel.dev/entity/3991c58b-6e98-52ec-aa30-822af204de0b
- **AdaptHealth Corp.** (other) — https://whiteintel.dev/entity/3991c58b-6e98-52ec-aa30-822af204de0b
- **ARS Pharmaceuticals, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/a9c00c55-4330-55f3-a417-febad978a7c8
- **Nuvalent, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/c311f0a0-a099-557a-ba70-bfce08965197
- **ARS Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/a9c00c55-4330-55f3-a417-febad978a7c8
- **Larimar Therapeutics, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/72e3523f-efab-5ee4-b03e-4139df749767
- **Mirum Pharmaceuticals, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/a485ead8-2cff-5533-b09d-c62eabdf701d
- **Oncology Institute, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/4fb4cbe0-0cf8-5556-b28c-8f0b5f7d4eb6
- **Singular Genomics Systems, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/bf67dc53-807a-500f-904c-d1c0a83a310e
- **Edgewise Therapeutics, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/8a5e122d-7278-5f7d-88fd-4cc49f252dff
- **Annexon, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/ea2cc909-5d92-5fdb-931f-208c65007c96
- **Nkarta, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/3ebe47b2-1755-5682-a49d-3331c6f8189a
- **Oncology Institute, Inc.** (director) — https://whiteintel.dev/entity/4fb4cbe0-0cf8-5556-b28c-8f0b5f7d4eb6
- **Schrodinger, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/97df95ba-afe9-514a-8d91-52dfbd0319dd
- **Revolution Medicines, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/69f58bea-eda5-5fda-9043-f7c5d5abebe9
- **Cabaletta Bio, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/ef30717a-59f7-5bee-82f2-b231ba7e9927
- **Korro Bio, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/71e9bcfd-4176-551b-b776-01b734a2fd82
- **AdaptHealth Corp.** (director) — https://whiteintel.dev/entity/3991c58b-6e98-52ec-aa30-822af204de0b
- **AdaptHealth Corp.** (tenpercentownerother) — https://whiteintel.dev/entity/3991c58b-6e98-52ec-aa30-822af204de0b
- **ARVINAS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/c68c871a-7d56-5616-92f8-6e15a2da829d
- **Protara Therapeutics, Inc.** (directorother) — https://whiteintel.dev/entity/d54e2413-cebc-5e01-bc86-3b7d84bd9785

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **DEERFIELD PRIVATE DESIGN FUND IV, L.P.**. Human view: https://whiteintel.dev/entity/bba401c5-eaa6-57ec-9730-e5eeb88b37f1 · Structured JSON: https://whiteintel.dev/api/public/dossier/bba401c5-eaa6-57ec-9730-e5eeb88b37f1._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._